Catalio Capital Management Closes $400M+ Fund IV to Fuel Breakthrough Biomedical Innovation
What You Should Know:
– Catalio Capital Management, LP (“Catalio”), a healthcare investment firm, today announced the successful close of its fourth venture fund, Catalio Nexus Fund IV (“Fund IV”), with over $400M in commitments…
Continue Reading